sodium,(Z,2S)-2-[[(Z,2S)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-6-diazonio-5-oxidohex-5-enoyl]amino]-6-diazonio-5-oxidohex-5-enoate

Modify Date: 2025-08-28 00:05:18

sodium,(Z,2S)-2-[[(Z,2S)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-6-diazonio-5-oxidohex-5-enoyl]amino]-6-diazonio-5-oxidohex-5-enoate Structure
sodium,(Z,2S)-2-[[(Z,2S)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-6-diazonio-5-oxidohex-5-enoyl]amino]-6-diazonio-5-oxidohex-5-enoate structure
Common Name sodium,(Z,2S)-2-[[(Z,2S)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-6-diazonio-5-oxidohex-5-enoyl]amino]-6-diazonio-5-oxidohex-5-enoate
CAS Number 55156-24-6 Molecular Weight 475.38800
Density N/A Boiling Point N/A
Molecular Formula C17H22N7NaO8 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name sodium,(Z,2S)-2-[[(Z,2S)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-6-diazonio-5-oxidohex-5-enoyl]amino]-6-diazonio-5-oxidohex-5-enoate
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C17H22N7NaO8
Molecular Weight 475.38800
Exact Mass 475.14300
PSA 271.05000

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RC6311000
CHEMICAL NAME :
L-Norleucine, 6-diazo-N-(6-diazo-N-L-gamma-glutamyl-5-oxo-L-norleuc yl)-5-oxo-, sodium salt
CAS REGISTRY NUMBER :
55156-24-6
LAST UPDATED :
199509
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C17-H23-N7-O8.xNa
MOLECULAR WEIGHT :
614.40
WISWESSER LINE NOTATION :
QVYZ2VMY2V1UNN&VMYVQ2V1UNN &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
388 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
262 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia Gastrointestinal - hypermotility, diarrhea Liver - other changes
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 23,3467,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
271 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4300 ug/kg/5D-I
TOXIC EFFECTS :
Gastrointestinal - changes in structure or function of endocrine pancreas Biochemical - Metabolism (Intermediary) - amino acids (including renal excretion) Related to Chronic Data - death
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 23,3467,1974

 Synonyms

Antibiotic 1719 sodium salt
Azotomycin sodium salt
Azotomycin sodium
1719 Sodium
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.